These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2143990)

  • 21. [Evaluation of the effectiveness of cisapride in the treatment of gastroesophageal reflux].
    Iacono G; Carroccio A; Montalto G; Cavataio F; Lorello D; Soresi M; Kazmierska I; Balsamo V
    Minerva Pediatr; 1992 Dec; 44(12):613-6. PubMed ID: 1301487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary gastro-oesophageal reflux disease and irritable oesophagus syndrome as causes of recurrent abdominal pain in children.
    Corrado G; Cavaliere M; Frandina G; Rea P; Pacchiarotti C; Capocaccia P; Cardi E
    Ital J Gastroenterol; 1996; 28(8):462-9. PubMed ID: 9032590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisapride decreases prolonged episodes of reflux in infants.
    Vandenplas Y; de Roy C; Sacre L
    J Pediatr Gastroenterol Nutr; 1991 Jan; 12(1):44-7. PubMed ID: 2061776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of gastro-oesophageal reflux in cystic fibrosis.
    Cucchiara S; Santamaria F; Andreotti MR; Minella R; Ercolini P; Oggero V; de Ritis G
    Arch Dis Child; 1991 May; 66(5):617-22. PubMed ID: 2039253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Arch Dis Child; 1992 May; 67(5):618-21. PubMed ID: 1599300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cisapride and cimetidine on 24-hour intraesophageal pH monitoring in patients with gastroesophageal reflux disease.
    Chojnacki J; Tkaczewski W; Wichan P; Grzegorczyk K; Klupińska G
    Mater Med Pol; 1992; 24(3):196-8. PubMed ID: 1307654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cisapride on gastroesophageal reflux in children with chronic bronchopulmonary disease: a double-blind cross-over pH-monitoring study.
    Saye ZN; Forget PP; Geubelle F
    Pediatr Pulmonol; 1987; 3(1):8-12. PubMed ID: 3588052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
    Hatlebakk JG; Berstad A
    Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between cisapride and Gaviscon with Carobel in the treatment of gastro-oesophageal reflux in infancy.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Ir Med J; 1992; 85(4 Suppl):14. PubMed ID: 1490841
    [No Abstract]   [Full Text] [Related]  

  • 30. Cisapride and the lazy lower oesophageal sphincter.
    Dent J
    J Gastroenterol Hepatol; 1989; 4(5):490-1. PubMed ID: 2491215
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of gastro-oesophageal reflux disease. Are there alternatives to omeprazole?
    Meuwissen SG; Klinkenberg-Knol EC
    Digestion; 1989; 44 Suppl 1():54-62. PubMed ID: 2575062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
    Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
    An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
    Ramirez B; Richter JE
    Aliment Pharmacol Ther; 1993 Feb; 7(1):5-20. PubMed ID: 8094981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antireflux medication on salivary drooling in children with cerebral palsy.
    Heine RG; Catto-Smith AG; Reddihough DS
    Dev Med Child Neurol; 1996 Nov; 38(11):1030-6. PubMed ID: 8913184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisapride treatment for gastro-oesophageal reflux in children.
    Augood C; Gilbert R; Logan S; MacLennan S
    Cochrane Database Syst Rev; 2002; (3):CD002300. PubMed ID: 12137654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN).
    Vandenplas Y; Ashkenazi A; Belli D; Boige N; Bouquet J; Cadranel S; Cezard JP; Cucchiara S; Dupont C; Geboes K
    Eur J Pediatr; 1993 Sep; 152(9):704-11. PubMed ID: 8223796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
    Smythe A; Bird NC; Troy GP; Globe J; Johnson AG
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisapride: its use in children.
    Newell SJ
    Br J Hosp Med; 1990 Dec; 44(6):408-9. PubMed ID: 2081312
    [No Abstract]   [Full Text] [Related]  

  • 39. [24-hour esophageal pH-metry in the evaluation of gastroesophageal reflux pathology].
    Accorsini M; Averbene C; Caiulo VA; Ughi C; Ceccarelli M
    Minerva Pediatr; 1992 May; 44(5):185-8. PubMed ID: 1620071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.
    Maddern GJ; Jamieson GG; Myers JC; Collins PJ
    Gut; 1991 May; 32(5):470-4. PubMed ID: 2040466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.